Cholestasis leads to liver cell death, fibrosis, cirrhosis, and eventually liver failure. Despite limited benefits, ursodeoxycholic acid (UDCA) is the only Food and Drug Administration-approved treatment for cholestatic disorders. Retinoic acid (RA) is a ligand for nuclear receptors that modulate bi
The NF-κB inhibitors attenuate hepatic injury in bile duct ligated rats
✍ Scribed by Savaş Demirbilek; Melih Akın; Kubilay Gürünlüoğlu; Nasuhi E. Aydın; Memet H. Emre; Erkan Taş; Rauf T. Aksoy; Selma Ay
- Publisher
- Springer-Verlag
- Year
- 2006
- Tongue
- English
- Weight
- 412 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0179-0358
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract __Nigella sativa__ (NS) has been shown to have antioxidant and antiinflammatory activities in different conditions. The goal of this study was to evaluate the effects of NS on cholestatic liver injury in rats. Thirty rats were recruited in the study as follows: Group 1, Bile duct ligati
The hepatic stellate cell (HSC), following a fibrogenic stimulus, is transformed from a quiescent to an activated cell. Cytokines induce NFB activity in activated but not in quiescent HSCs with subsequent expression of NFBresponsive genes, such as intercellular adhesion molecule (ICAM)-1 and interle